Track the MIRA PHARMACEUTICALS, INC. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €31.1m. The latest transaction was filed on 3 October 2025 (Attribution). Among the most active insiders: Aminov Erez. The full history is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€2m
3 ops.
Buy Volume
€487,185
3 ops.
Sell Volume
32Σ signal
Buys €2m€487,185 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
157,170 shares@ US$7.0057.0% of flowCommon StockSEC:0000897069-23-001091:0
Canonical exit: 31 Oct 2023 (T+90)
9 of 9 declarations
About MIRA PHARMACEUTICALS, INC.
MIRA PHARMACEUTICALS, INC. is a company listed on the XNAS market, specializing in the development of innovative pharmaceutical solutions. It focuses on the research and commercialization of drugs for various therapeutic areas.